SphK1 was co-localized with the LSEC marker CD31 in the MASH livers of CDD-treated mice, and treatment with TNF-α induced an elevation of SphK1 mRNA in isolated LSECs (S5A and S5B Fig). Here, TNF is linked to craniodiaphyseal dysplasia.